Literature DB >> 22189275

Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction.

Junya Shirai1, Hideyuki Sugiyama, Shinji Morimoto, Hironobu Maezaki, Yasuharu Yamamoto, Satoshi Okanishi, Izumi Kamo, Shiho Matsumoto, Keiko Ishigami, Nobuhiro Inatomi, Akio Imanishi, Makiko Kawamoto, Naoki Tarui, Tadatoshi Hashimoto, Yoshinori Ikeura.   

Abstract

The synthesis and biological evaluation of a series of novel 3-phenylpiperidine-4-carboxamide derivatives are described. These compounds are generated by hybridization of the substructures from two types of tachykinin NK(1) receptor antagonists. Compound 42 showed high metabolic stability and excellent efficacy in the guinea-pig GR-73637-induced locomotive activity assay at 1 and 24h after oral administration. It also exhibited good pharmacokinetic profiles in four animal species, and a low potential in a pregnane X receptor induction assay.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189275     DOI: 10.1016/j.bmc.2011.11.048

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  Dual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics.

Authors:  Cecilia Betti; Joanna Starnowska; Joanna Mika; Jolanta Dyniewicz; Lukasz Frankiewicz; Alexandre Novoa; Marta Bochynska; Attila Keresztes; Piotr Kosson; Wioletta Makuch; Joost Van Duppen; Nga N Chung; Jozef Vanden Broeck; Andrzej W Lipkowski; Peter W Schiller; Frans Janssens; Marc Ceusters; François Sommen; Theo Meert; Barbara Przewlocka; Dirk Tourwé; Steven Ballet
Journal:  ACS Med Chem Lett       Date:  2015-10-31       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.